News
22 Sep 2020
Terumo’s PLAJEX Provides a Solution for a New Osteoporosis Treatment Developed and Manufactured on Contract
Terumo Corporation (TSE: 4543) today announced that a new osteoporosis medication, Teribone
Asahi Kasei Pharma has been providing lyophilized vial formulation Teribone
Mentioned Companies
Terumo Europe NV - TPS
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance